Subsequent events (Details Narrative) - USD ($) $ in Millions |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Feb. 09, 2024 |
Feb. 29, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Subsequent Event [Line Items] | ||||
| Share based compensation expense | $ 1.8 | $ 3.0 | ||
| Subsequent Event [Member] | Board of Directors [Member] | 2019 Incentive Award Plan [Member] | ||||
| Subsequent Event [Line Items] | ||||
| Restricted shares, granted | 42,088 | |||
| Share based compensation expense | $ 0.4 | |||
| Aimia Pet Healthco, Inc. [Member] | Subsequent Event [Member] | ||||
| Subsequent Event [Line Items] | ||||
| Number of shares of common stock | 45,629 | |||
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|